Medical research

Monkey-infecting virus may provide part of future HIV vaccine

A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has shown promise as a potential component of a vaccine against Human Immunodeficiency Virus (HIV), in a new study from scientists at ...

HIV & AIDS

A cure for HIV? Feasible but not yet realized

This week a team of scientists and physicians from the U.K. published news of a second HIV positive man, in London, who is in long-term (18-month) HIV remission after undergoing treatment for Hodgkins lymphoma. The unexpected ...

HIV & AIDS

Ending HIV transmission by 2030

After four decades of fighting AIDS and the human immunodeficiency virus that causes it, the U.S. government is pressing forward with a plan to end HIV transmission in the country by 2030.

Diseases, Conditions, Syndromes

Combination therapy treats leishmaniasis, HIV patients

Coinfection with visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) has been observed in at least 35 countries on four continents and requires special case management. Currently, the World Health Organization ...

HIV & AIDS

Aspirin could reduce HIV infections in women

With nearly two million new infections and one million associated deaths each year, the HIV (human immunodeficiency virus) pandemic is alive and well. Thirty-seven million people are now living with HIV, more than half of ...

HIV & AIDS

Cellphone technology developed to detect HIV

The management of human immunodeficiency virus 1 (HIV), an autoimmune disorder that cripples the immune system by attacking healthy cells, remains a major global health challenge in developing countries that lack infrastructure ...

page 12 from 40